GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide carry the clinical evidence: STEP for semaglutide ( The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024)
getProductCode(psProduct) psProduct } priceList[psProduct } priceList[psProduct } priceList[psProduct } psProduct } Special Offer NEW
The therapy typically lasts about 30 to 60 minutes, during which a healthcare professional monitors the infusion
The company advises patients to take their pill immediately upon waking up, with 4 ounces of water, and to then wait for at least 30 minutes before eating or drinking anything else
Additionally, those with severe respiratory conditions, such as advanced COPD or pulmonary fibrosis, should consult their healthcare provider before undergoing nebulization therapy
Lab-tested batch with full traceability Sealed pharmaceutical pack Discreet UK tracked delivery Add 4 more pens for 10% off